|Articles|November 7, 2006

Prentice to Step Down as SACHRP Chairman

First SACHRP Chairman Resigning

7 November-Ernest Prentice is stepping down as chairman of the Secretary's Advisory Committee on Human Research Protections (SACHRP).

Prentice has served as SACHRP chairman since the committee was chartered 1 October 2002 as a successor body to the National Human Research Protections Advisory Committee.

This past October the SACHRP had its charter renewed for a two-year term.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Prentice to Step Down as SACHRP Chairman

Related Content

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

What a Lean Development Model Actually Means for Biotech Operations Today

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

Why Commercialization Readiness Can No Longer Wait Until End of Phase II

Trending on Applied Clinical Trials Online

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

ACT Brief: NIH Funding Reshaping Development Strategy, Business Decision Setting Execution Course, and Complex Modality Platform Gaps